Advanced molecular diagnostic tools: A step closer to precision medicine in neuro-oncology

Elisa Aquilanti^{1

2}, Patrick Y Wen^{1

3

4}

Affiliations

¹ Division of Neuro-Oncology, Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA, USA.
² Department of Medicine, Harvard Medical School, Boston, MA, USA.
³ Division of Neuro-Oncology, Department of Neurology, Brigham and Women's Hospital, Boston, MA, USA.
⁴ Department of Neurology, Harvard Medical School, Boston, MA, USA.

Editorial

Elisa Aquilanti et al. Neuro Oncol. 2023.

. 2023 Oct 3;25(10):1750-1751.

doi: 10.1093/neuonc/noad132.

Elisa Aquilanti^{1

2}, Patrick Y Wen^{1

3

4}

¹ Division of Neuro-Oncology, Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA, USA.
² Department of Medicine, Harvard Medical School, Boston, MA, USA.
³ Division of Neuro-Oncology, Department of Neurology, Brigham and Women's Hospital, Boston, MA, USA.
⁴ Department of Neurology, Harvard Medical School, Boston, MA, USA.

No abstract available

Comment on

Molecular diagnostic tools for the World Health Organization (WHO) 2021 classification of gliomas, glioneuronal and neuronal tumors; an EANO guideline.
Sahm F, Brandner S, Bertero L, Capper D, French PJ, Figarella-Branger D, Giangaspero F, Haberler C, Hegi ME, Kristensen BW, Kurian KM, Preusser M, Tops BBJ, van den Bent M, Wick W, Reifenberger G, Wesseling P. Sahm F, et al. Neuro Oncol. 2023 Oct 3;25(10):1731-1749. doi: 10.1093/neuonc/noad100. Neuro Oncol. 2023. PMID: 37279174 Free PMC article.

1. Louis DN, Perry A, Reifenberger G, et al. . The 2016 World Health Organization Classification of Tumors of the Central Nervous System: A summary. Acta Neuropathol. 2016;131(6):803–820. - PubMed
1. Louis DN, Perry A, Wesseling P, et al. . The 2021 WHO Classification of Tumors of the Central Nervous System: A summary. Neuro Oncol. 2021;23(8):1231–1251. - PMC - PubMed
1. Sahm F, Brandner S, Bertero L, et al. . Molecular diagnostic tools for the World Health Organization (WHO) 2021 classification of gliomas, glioneuronal and neuronal tumors; an EANO guideline. Neuro Oncol. 2023;25(10):1731–1749. - PMC - PubMed
1. Brown NA, Elenitoba-Johnson KSJ.. Enabling precision oncology through precision diagnostics. Annu Rev Pathol. 2020;15:97–121. - PubMed
1. Capper D, Reifenberger G, French PJ, et al. . EANO guideline on rational molecular testing of gliomas, glioneuronal, and neuronal tumors in adults for targeted therapy selection. Neuro Oncol. 2023;25(5):813–826. - PMC - PubMed